CPR:MILDavide Campari-Milano N.V. Analysis
Data as of 2026-08-26 - not real-time
€5.90
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Davide Campari-Milano N.V. is neutral at €5.90, with no clear ordering between short and long averages. It has gained 6.4% over the past 30 days. Relative strength is 59.0 — neutral — and the MACD signal is bearish. The recent range runs from support at €5.70 up to resistance at €6.39.
The shares look fair at 25.7 times earnings, though no sector average was available for comparison. Analyst price targets sit 19.1% above the current price. The 1.67% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 22.5%, a beta of -0.01 and a maximum drawdown of 20.8%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
The shares look fair at 25.7 times earnings, though no sector average was available for comparison. Analyst price targets sit 19.1% above the current price. The 1.67% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 22.5%, a beta of -0.01 and a maximum drawdown of 20.8%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
Davide Campari-Milano N.V. reported its latest earnings on May 6, 2026, drawing attention to revenueDavide Campari-Milano N.V. reported higher sales and profitability for Q1 2026, supported by strongAs spirits demand shifts toward premium brands amid economic uncertainty, Campari's iconic portfolio
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 5.89
- MACD momentum is negative
- 30-day price change of +6.4%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 5.89
- Analyst targets imply +19.1% versus the current price
- MACD momentum is negative
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Analyst targets imply +19.1% versus the current price
- Revenue contracting at -1.0%
- P/E ratio of 25.7
Key Metrics & Analysis
Financial Health
Revenue Growth-1.00%
Profit Margin8.87%
P/E Ratio25.7
ROE6.68%
ROA4.21%
Debt/Equity70.27
P/B Ratio1.8
Op. Cash Flow€556.6M
Free Cash Flow€172.1M
Technical Analysis
TrendNeutral
RSI59.0
Support€5.70
Resistance€6.39
MA 20€5.91
MA 50€5.69
MA 200€5.89
MACDBearish
VolumeDecreasing
Fear & Greed Index93.84
Valuation
Fair Value€0.09
Target Price€7.03
Upside/Downside19.09%
GradeFair
TypeBlend
Dividend Yield1.67%
Risk Assessment
Beta-0.01
Volatility22.47%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.